Skip to content

Clinical trials

Phase 3 Hepatitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Phase: Phase 3 Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20061
20072
20091
20101
20111
20121
20135
20141
20171
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
Dynavax Technologies Corporation3
GlaxoSmithKline2
Human Genome Sciences Inc.2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
AbbVie1
Bausch Health Americas, Inc.1
Janssen R&D Ireland1
National Institute of Allergy and Infectious Diseases (NIAID)1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis22
Hepatitis C8
Hepatitis C, Chronic7
Hepatitis B5
Hepatitis, Chronic5
Liver Diseases5
Hepatitis, Viral, Human4
Virus Diseases4
Digestive System Diseases3
Enterovirus Infections3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.